Zentalis Pharmaceuticals Inc (ZNTL)

Zentalis Pharmaceuticals Inc Azioni (ZNTL) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	40.56	-	-	-	-
Operating Expenses	3.82% 65.33	67.92	62.72	103.92	64.95
Benefits Costs and Expenses	30.38	-	-	-	-
Costs And Expenses	30.38	-	-	-	-
Operating Income/Loss	63.54% -24.77	-67.92	-62.72	-103.92	-64.95
Income/Loss Before Equity Method Investments	116.67% 10.18	-61.07	-55.51	-99.47	-60.84
Income/Loss From Equity Method Investments	-	-	-	-13.70	-2.31
Income/Loss From Continuing Operations Before Tax	113.21% 10.18	-77.09	-55.51	-99.47	-60.84
Income Tax Expense/Benefit	205.93% 0.143	-0.135	0.031	-0.605	0.108
Income/Loss From Continuing Operations After Tax	113.05% 10.04	-76.95	-55.54	-98.86	-60.95
Net Income/Loss	116.48% 10.04	-60.94	-55.54	-112.56	-63.26
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	27.27% -0.028	-0.022	-0.012	-0.037	-0.043
Basic Average Shares	3,821% 70.90	1.808	70.61	60.79	59.28
Diluted Average Shares	3,838% 71.19	1.808	70.61	60.79	59.28
Basic Earnings Per Share	116.87% 0.14	-0.83	-0.79	-1.85	-1.07
Diluted Earnings Per Share	116.87% 0.14	-0.83	-0.79	-1.85	-1.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-